Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer procoagulant

S G Gordon1

  • 1Department of Pathology, University of Colorado, Health Sciences Center, Denver 80262.

Methods in Enzymology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Cancer procoagulant (CP), a cysteine proteinase, has well-defined assays and properties. Future research will use molecular tools to understand CP

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of an interactive, stereoscopic three-dimensional viewer to evaluate atrial septal defects in five dogs.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2025
Same author

Veterinary echocardiographers' preferences for image selection, timing, and caliper placement for left atrial two-dimensional size assessment in dogs: the BENEFIT project.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2025
Same author

Veterinary echocardiographers' preferences for left atrial size assessment in dogs: the BENEFIT project.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2023
Same author

Veterinary echocardiographers' preferences for left atrial size assessment in cats: the BENEFIT project.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2023
Same author

Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2023
Same author

Advanced imaging in an adult dog with anomalous origin of the left coronary artery from the pulmonary artery and extensive collateral coronary circulation.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2023
Same journal

1,2-Aminothiol-specific conjugation for dual-color fluorescent labeling via ultrafast TAMM conjugates.

Methods in enzymology·2026
Same journal

Nitrone dipoles in bioorthogonal chemistry applications.

Methods in enzymology·2026
Same journal

Bioorthogonal labeling of sialic acid isomers for detection of glycoconjugates by mass spectrometry imaging and microscopy.

Methods in enzymology·2026
Same journal

Bioorthogonal photocatalytic proximity labeling for quantitative mapping of cell-cell interactions.

Methods in enzymology·2026
Same journal

inCu-click: Enabling copper-catalyzed click chemistry inside living cells.

Methods in enzymology·2026
Same journal

Site-specific antibody labeling via endo-S2 mediated Fc glycan remodeling.

Methods in enzymology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Enzymology
  • Molecular Biology

Background:

  • Cancer procoagulant (CP) is a distinct cysteine proteinase.
  • Extensive research has characterized its properties and enzymatic activity.
  • Sensitive and reproducible assays for CP are currently available.

Purpose of the Study:

  • To review the current understanding of cancer procoagulant.
  • To highlight the availability of research tools for its study.
  • To outline future directions for molecular and cellular investigations.

Main Methods:

  • Purification of cancer procoagulant using various procedures.
  • Characterization of enzymatic properties.
  • Evaluation of proteinase inhibitors' effects on CP in reduced environments.

Related Experiment Videos

Main Results:

  • Cancer procoagulant has been successfully purified.
  • Its biochemical and enzymatic characteristics are well-documented.
  • Many low molecular weight inhibitors are effective against CP in reduced conditions.

Conclusions:

  • Cancer procoagulant is a well-characterized enzyme with available assays.
  • Future research will leverage molecular and genetic tools for deeper understanding.
  • Specific inhibitors and molecular probes are anticipated to advance functional insights.